Bio-Rad Laboratories, Inc. (BIO)
$363.73-0.19%Close
SELLBEAR · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9.8B
- Beta
- 1.07
- P/E (TTM)
- 43.67
- Short % float
- 6.62%
- Days to cover
- 4.3
- SI change
- +18.4%
- 1W
- -1.38%
- 1M
- -1.31%
- vs SPY 1W
- -1.24%
- vs SPY 1M
- -3.81%
Industry peers
FMP comparable companies · ranked by market cap
- TMOBUYThermo Fisher Scientific Inc.$243.3BBULLQ 18$658.02+0.12%
- DHRBUYDanaher Corporation$154.6BRECOVERYQ 36$219.87+0.74%
- RVTYBUYRevvity, Inc.$17.2BBULLQ 12$154.18-0.34%
- TECHBUYBio-Techne Corporation$11.3BBULLQ 19$72.46-0.11%
- RGENSELLRepligen Corporation$9.8BBEARQ 26$173.88+1.69%
- BRKRSELLBruker Corporation$9.0BBEARQ 8$58.84-0.11%
- MRVISELLMaravai LifeSciences Holdings, Inc.$2.1BCRISISQ -2$7.44-7.51%
- AZTABUYAzenta, Inc.$1.7BRECOVERYQ 9$37.72+0.26%
- PACBBUYPacific Biosciences of California, Inc.$724MCRISISQ 4$2.33-2.38%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on BIO?
- LOPJLB’s latest quantitative signal on Bio-Rad Laboratories, Inc. (BIO) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is BIO in?
- Bio-Rad Laboratories, Inc. (BIO) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Bio-Rad Laboratories, Inc. (BIO) do?
- Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsib…